Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Protease inhibitor-induced lipodystrophy.

K Williamson1, A C Reboli, S M Manders

  • 1Department of Medicine, University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School at Camden, USA.

Journal of the American Academy of Dermatology
|April 3, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Review of the Management of Obesity in Primary Care.

Clinical obesity·2025
Same author

Place-based household vouchers for locally supplied fruit and vegetables: the Fresh Street pilot cluster randomised controlled trial.

BMC public health·2025
Same author

Expectations of therapeutic radiography students in Wales about transitioning to practice during the Covid-19 pandemic as registrants on the HCPC temporary register.

Radiography (London, England : 1995)·2020
Same author

The radiology impact of healthcare errors during shift work.

Radiography (London, England : 1995)·2020
Same author

Microbial evaluation of automated sorting systems in stone fruit packinghouses during peach packing.

International journal of food microbiology·2018
Same author

Safety and efficacy of high-dose enteral, intravenous, and transdermal clonidine for the acute management of severe intractable childhood dystonia and status dystonicus: An illustrative case-series.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2017

Protease inhibitor therapy for HIV infection can cause lipodystrophy, a condition characterized by abnormal fat distribution. This case highlights the importance of recognizing this side effect in patients with human immunodeficiency virus.

Area of Science:

  • Endocrinology
  • Infectious Diseases
  • Pharmacology

Background:

  • Cushing's disease classically presents with lipodystrophy, including central obesity, moon facies, and buffalo hump.
  • Protease inhibitors are a critical component of highly active antiretroviral therapy (HAART) for HIV infection.
  • Emerging evidence suggests a link between protease inhibitor use and the development of lipodystrophy syndromes.

Observation:

  • This report details a patient who developed lipodystrophy.
  • The patient was undergoing treatment with protease inhibitors for human immunodeficiency virus (HIV) infection.

Findings:

  • The observed lipodystrophy was directly attributed to the protease inhibitor therapy.
  • This represents a secondary form of lipodystrophy, distinct from endocrine causes like Cushing's disease.

Related Experiment Videos

Implications:

  • Clinicians should be vigilant for signs of lipodystrophy in HIV patients on protease inhibitor regimens.
  • Understanding this association is crucial for managing treatment-related adverse effects in HIV care.
  • Further research may explore mechanisms and alternative therapeutic strategies to mitigate this side effect.